regulatory affairs

world global globe ex-US country map regions

Pharma

Lack of global regulatory alignment spurs bad actors, FDA says

If a gene therapy is approved in the U.S., patients in Brazil can sue for access. It’s why global regulators need to work together, Peter Marks said.

Annalee Armstrong May 9, 2024 10:15am

podium first place first line medal win champion

Pharma heads for cancer first line, causing early-stage rethink

Nov 17, 2023 3:00am

FDA clipboard

Regulatory tracker: Bayer adds new Kerendia CV outcomes nod

Aug 29, 2022 9:48am